Gano Kyle sold NBIX

February 13, 2025 · Form 4 insider transaction

Gano Kyle sold 1,352 shares of Neurocrine Biosciences, Inc. at $116.84 per share, a transaction worth $158.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
1,352
Price
$116.84
Total value
$158.0K
InsiderGano Kyle
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 13, 2025
Filing dateFebruary 14, 2025
Shares owned after138,872
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.; Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $116.02 to $118.26. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

View the original Form 4 on SEC EDGAR
Gano Kyle sold NBIX: February 13, 2025 | Insider Trading Screener